| Literature DB >> 19760259 |
Silke Nuber1, Thomas Franck, Hartwig Wolburg, Ulrike Schumann, Nicolas Casadei, Kristina Fischer, Carsten Calaminus, Bernd J Pichler, Sittinan Chanarat, Peter Teismann, Jörg B Schulz, Andreas R Luft, Jürgen Tomiuk, Johannes Wilbertz, Antje Bornemann, Rejko Krüger, Olaf Riess.
Abstract
Synphilin-1 has been identified as an interacting protein of alpha-synuclein, Parkin, and LRRK2, proteins which are mutated in familial forms of Parkinson disease (PD). Subsequently, synphilin-1 has also been shown to be an intrinsic component of Lewy bodies in sporadic PD. In order to elucidate the role of synphilin-1 in the pathogenesis of PD, we generated transgenic mice overexpressing wild-type and mutant (R621C) synphilin-1 driven by a mouse prion protein promoter. Transgenic expression of both wild-type and the R621C variant synphilin-1 resulted in increased dopamine levels of the nigrostriatal system in 3-month-old mice. Furthermore, we found pathological ubiquitin-positive inclusions in cerebellar sections and dark-cell degeneration of Purkinje cells. Both transgenic mouse lines showed significant reduction of motor skill learning and motor performance. These findings suggest a pathological role of overexpressed synphilin-1 in vivo and will help to further elucidate the mechanisms of protein aggregation and neuronal cell death.Entities:
Mesh:
Substances:
Year: 2010 PMID: 19760259 DOI: 10.1007/s10048-009-0212-2
Source DB: PubMed Journal: Neurogenetics ISSN: 1364-6745 Impact factor: 2.660